Dr. Nick Harvey of the MRC Epidemiology Resource Center, University of Southhampton, was presented with the 2009 ESCEO-IOF Alliance for Better Bone Health Young Investigator Award at the ECCEO9-IOF meeting held in Athens from March 18 to 21, 2009.
The award honorarium of 2,000 euro is sponsored by the Alliance for Better Bone Health (P&G Pharmaceuticals and Sanofi-Aventis) in recognition of outstanding research, based on the most highly scored abstract submitted by a lead investigator under the age of 40. Dr Harvey was presented with the award certificate by IOF President John Kanis, David Cahall of Sanofi-Aventis and Stephane Horlait of P&G Pharmaceuticals at an award ceremony on March 21, 2009.
Entitled "Indices of intrauterine growth may differentially predict postnatal development of skeletal size and volumetric density", the award-winning abstract describes the results of a study on 380 children followed-up in utero, in which ultrasound was used to measure the velocity of both fetal femur and abdominal growth between 19 and 34 weeks gestation. The measurements were then related to bone size and density at 4 years of age. Results indicate that tracking of skeletal growth has its origins in utero and that there is a possible discordance between influences on volumetric density and skeletal size.
World Congress on Osteoporosis – IOF WCO-ECCEO10
Don't miss the premiere global skeletal health meeting of 2010, to be held in Florence, Italy from May 5- 8, 2010. Complete information is available on the Congress website www.iofwco-ecceo10.org.
Abstract submission deadline: February 4, 2010.
ABOUT ESCEO
The European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) is a non-profit organization, dedicated to a close interaction between clinical scientists dealing with rheumatic disorders, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policy makers, to integrate the management of osteoporosis and osteoarthritis within the comprehensive perspective of health resources utilization. The objective of ESCEO is to provide practitioners with the latest clinical and economic information, allowing them to organize their daily practice, in an evidence-based medicine perspective, with a cost-conscious perception.
ABOUT IOF
The International Osteoporosis Foundation (IOF) is a nongovernmental umbrella organization dedicated to the worldwide fight against osteoporosis, the disease known as "the silent epidemic". IOF's members – committees of scientific researchers, patient, medical and research societies and industry representatives from around the world – share a common vision of a world without osteoporotic fractures. Launched in 1998 with the merger of the European Foundation for Osteoporosis (EFFO, founded in 1987) and the International Federation of Societies on Skeletal Diseases, IOF now represents 191 societies in 91 locations. www.iofbonehealth.org